[ad_1] BCFC/iStock Editorial through Getty Images McKesson Corp. (NYSE:MCK) is in superior discussions to acquire a controlling stake in a privately held operator of oncology clinics.…
Browsing: cancer
[ad_1] Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business targeted on producing radioactive chemical compounds…
[ad_1] JHVEPhoto BeiGene (NASDAQ:BGNE) has acquired FDA Fast Track Designation for its investigational cancer therapy. BGB-16673, an orally accessible BTK-targeting chimeric degradation activation compound, gained fast…
[ad_1] Regeneron Pharmaceuticals (NASDAQ:REGN) mentioned on Monday its bispecific antibody Ordspono (odronextamab) has been cleared by the European Commission for the remedy of relapsed/refractory follicular lymphoma…
[ad_1] Dr_Microbe A U.S. FDA panel of advisors will meet in late September to debate whether or not to restrict using immune checkpoint inhibitors to deal…
[ad_1] BCFC/iStock Editorial by way of Getty Images McKesson Corp. (NYSE:MCK) is in superior discussions to acquire a controlling stake in a privately held operator of…
[ad_1] Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business centered on producing radioactive chemical compounds…
[ad_1] Dr_Microbe A U.S. FDA panel of advisors will meet in late September to debate whether or not to restrict using immune checkpoint inhibitors to deal…
[ad_1] BCFC/iStock Editorial through Getty Images McKesson Corp. (NYSE:MCK) is in superior discussions to acquire a controlling stake in a privately held operator of oncology clinics.…
[ad_1] Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business centered on producing radioactive chemical compounds…